In this BoardsCast episode, we continue Tobias Chapter 95 — Liver and Biliary System by confronting the most seductive trap in liver surgery:
“The CT looked operable… so we operated.”
That’s how you get the haunting outcome: technically perfect lobectomy, great hemostasis, clean closure… and the patient still doesn’t survive the week because you prioritized anatomical opportunity over biologic cost.
This episode rebuilds the decision framework the boards want you to have cold: liver resection is not a “remove the lump” problem. It’s a physiologic calculation based on distribution, reserve, and flow.
You’ll learn:
- Why liver surgery is biology over anatomy (the “factory wing” model)
- The blood supply math that changes your risk assessment: portal vein ≈ 80% flow and 50% oxygen
- The hard thresholds: dogs can tolerate ~65–70% acute liver removal, but mortality spikes near ~84% due to fatal portal hypertension
- The 3 buckets that decide action: benign nodular changes (usually don’t touch), primary tumors (massive vs nodular/diffuse), and metastatic disease (systemic problem)
- Why massive HCC is the “jackpot” surgical candidate (solitary, lobar) and why nodular/diffuse forms are surgical dead ends
- The risk multipliers that turn “resectable” into lethal: portal hypertension (post-hepatectomy portal pressure > 16 mmHg), acquired shunts/ascites, biliary obstruction, and diabetes (loss of insulin’s trophic signal for regeneration)
- The predictable decision errors: removing incidental nodules, debulking diffuse disease, ignoring portal HTN, and trusting imaging without tissue/physiology
This episode gives you the board-level governing rule:
The CT doesn’t decide. The scalpel doesn’t decide. Reserve and perfusion decide.
🎁 Simini Bonus
Claim your free sample of Simini Protect Lavage (just cover shipping):
https://www.simini.com/evaluation-kit
Listen On: Spotify | Apple Podcasts | Amazon Music
